Cytokines and inflammatory mediators in cystic fibrosis
نویسندگان
چکیده
منابع مشابه
Anti-inflammatory cytokines in cystic fibrosis lung disease.
Lung inflammation plays a pivotal role in the pathogenesis of airway disease in cystic fibrosis (CF). An imbalance between pro- and anti-inflammatory mediators has been observed and a deficiency in the anti-inflammatory response has been proposed, but this concept remains controversial. In the present study, the concentrations of two anti-inflammatory mediators, lipoxin A (LxA4) and Clara cell ...
متن کاملSilica-Induced Inflammatory Mediators and Pulmonary Fibrosis
Silicosis continues to be a lung disease with significant morbidity and mortality. Although silicainduced lung injury and cell activation and/or death has been investigated over the past several years, basic research continues to reveal the cell: cell and cell: mediator interactions critical to these events. This Chapter will emphasize the production and participation of several inflammatory cy...
متن کاملInflammatory cytokines in heart failure: mediators and markers.
Evidence from both experimental and clinical trials indicates that inflammatory mediators are of importance in the pathogenesis of chronic heart failure (HF) contributing to cardiac remodeling and peripheral vascular disturbances. Several studies have shown raised levels of inflammatory cytokines such as tumor necrosis factor (TNF)α, interleukin (IL)-1β and IL-6 in HF patients in plasma and cir...
متن کاملAirway iron and iron-regulatory cytokines in cystic fibrosis.
Iron availability is critical to Pseudomonas aeruginosa. The current authors determined sputum iron, ferritin, microalbumin levels and total cell counts (TCC) in 19 adult patients with cystic fibrosis (CF) during an acute exacerbation and repeated analyses following a median of 12 days antibiotic treatment. The current authors also determined sputum interleukin (IL)-1beta and tumour necrosis fa...
متن کامل[Anti-inflammatory therapy in cystic fibrosis].
Cystic fibrosis lung inflammation is early, sustained and severe and would justify an anti-inflammatory treatment. At present, the inhaled corticosteroid treatment did not give evidence of efficacy, contrary to the oral presentation, but at the cost of side effects. Azithromycin gives more encouraging results with a good tolerance. New molecules are in the process of validation.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Cystic Fibrosis
سال: 2004
ISSN: 1569-1993
DOI: 10.1016/j.jcf.2004.06.006